Status:

RECRUITING

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

Lead Sponsor:

University of Maryland, Baltimore

Collaborating Sponsors:

National Eye Institute (NEI)

Conditions:

Glaucoma

Eligibility:

All Genders

18+ years

Brief Summary

This pilot study evaluates the biomechanical properties of the cornea in glaucoma patients using Brillouin microscopy, a non-contact imaging technique. The study aims to compare corneal stiffness betw...

Detailed Description

This study explores the biomechanical properties of the cornea in patients with glaucoma using a novel, non-contact imaging technique called Brillouin microscopy. The technology allows in vivo assessm...

Eligibility Criteria

Inclusion

  • \- Age 18 years or older
  • Diagnosis of primary open angle glaucoma (POAG) or no history of glaucoma (for controls)
  • Open angle on gonioscopy (Shaffer grade 3 or 4)
  • Best-corrected visual acuity of 20/25 or better
  • Refractive error between +3.00 and -5.00 diopters
  • No prior use of topical glaucoma medications
  • Diagnosis of:
  • High Tension Glaucoma (IOP ≥ 22 mmHg on 3 visits)
  • Normal Tension Glaucoma (IOP ≤ 21 mmHg on 3 visits)
  • OR age-matched control with normal optic nerve and visual fields

Exclusion

  • Corneal abnormalities or conditions interfering with Brillouin or applanation tonometry
  • Retinal diseases affecting RNFL (e.g., macular traction)
  • History of ocular surgery or laser
  • Diagnosis of diabetes
  • History of uveitis
  • History of prolonged steroid use
  • Neurodegenerative or systemic diseases (e.g., multiple sclerosis, Alzheimer's, Parkinson's, schizophrenia)
  • Unreliable visual fields
  • Contraindications to beta blockers (e.g., bradycardia, severe pulmonary disease)
  • Moderate to severe glaucoma (per Hodapp-Anderson-Parrish criteria)
  • History of contact lens use
  • Low blood pressure

Key Trial Info

Start Date :

September 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06993597

Start Date

September 1 2025

End Date

June 1 2026

Last Update

September 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Maryland School of Medicine

Baltimore, Maryland, United States, 21201-1757